Depigmentation--a rare side effect to intra-articular glucocorticoid treatment

Intra-articular glucocorticoid injections are often used in patients with rheumatoid arthritis, either as bridging therapy or in periods with increased disease activity. We present a case of local skin depigmentation that occurred at the site of injection in a dark-skinned patient. Depigmentation is...

Full description

Saved in:
Bibliographic Details
Published in:Clinical rheumatology 2004-08, Vol.23 (4), p.373-375
Main Authors: Rogojan, Cornelia, Hetland, Merete Lund
Format: Article
Language:English
Subjects:
Betamethasone - administration & dosage
Betamethasone - adverse effects
Glucocorticoids - administration & dosage
Glucocorticoids - adverse effects
Humans
Injections, Intra-Articular
Male
Middle Aged
Pigmentation Disorders - chemically induced
Pigmentation Disorders - pathology
Remission, Spontaneous
Skin Pigmentation - drug effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intra-articular glucocorticoid injections are often used in patients with rheumatoid arthritis, either as bridging therapy or in periods with increased disease activity. We present a case of local skin depigmentation that occurred at the site of injection in a dark-skinned patient. Depigmentation is a rare complication of such therapy but may have important implications for dark-skinned patients.
ISSN:0770-3198
1434-9949
DOI:10.1007/s10067-004-0905-8